Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.
about
Early alterations of brain cellular energy homeostasis in Huntington disease modelsMetabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersNeurodegenerative disease and adult neurogenesisTriheptanoin improves brain energy metabolism in patients with Huntington diseaseDietary intake in adults at risk for Huntington disease: analysis of PHAROS research participantsBesides Huntington's disease, does brain-type creatine kinase play a role in other forms of hearing impairment resulting from a common pathological cause?Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling.A two years longitudinal study of a transgenic Huntington disease monkey.Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease.Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expressionMetformin intake associates with better cognitive function in patients with Huntington's disease.BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal CancerBody composition in premanifest Huntington's disease reveals lower bone density compared to controlsMuscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophyNo evidence of impaired gastric emptying in early Huntington's Disease.Altered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington's diseaseType 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's diseaseHuntington's Disease and Striatal Signaling.Progressive Impairment of Lactate-based Gluconeogenesis in the Huntington's Disease Mouse Model R6/2Cystathionine Levels in Patients With Huntington DiseaseQuantitative 1H NMR. Development and potential of an analytical method: an updateTissue-specific and nutrient regulation of the branched-chain α-keto acid dehydrogenase phosphatase, protein phosphatase 2Cm (PP2Cm).White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington's Disease.Measures of growth in children at risk for Huntington diseaseNovel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.A Metabolic Study of Huntington's Disease.Expression of mutant huntingtin in leptin receptor-expressing neurons does not control the metabolic and psychiatric phenotype of the BACHD mouseMetabolic disruption identified in the Huntington's disease transgenic sheep model.Sleep deficits but no metabolic deficits in premanifest Huntington's diseaseCatabolic Defect of Branched-Chain Amino Acids Promotes Heart FailureGlycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat dietThe gene coding for PGC-1alpha modifies age at onset in Huntington's DiseaseIntegration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samplesA large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease.Molecular mechanisms and potential therapeutical targets in Huntington's disease.
P2860
Q23912810-DBEC5C5E-7053-40A1-9D34-1C1BF85FEDC4Q24562763-5D728BC1-F060-46C7-89BB-CE6F91625E17Q28307113-3E6F19AF-87D0-4598-BE13-C059EF46A589Q28388261-21596020-06BC-486A-8694-3FD3EB3CA47AQ30435217-D74369E1-3959-4C2D-9916-8027BE568C4EQ30474238-23943431-8E10-46AD-8A6A-04B569B0BBC7Q30497024-8B87D9AA-8F4F-4D70-BC07-4FCDDCA4F91EQ30535295-017448C9-639C-4442-95DD-582EBFEC511EQ30577737-20628C69-49CC-4370-AC59-7A10B0C20366Q30885784-1D335F2C-D461-4F56-986E-0A6B4174441CQ33690991-D7781A4C-117D-4D64-94AB-190422B53BADQ33755845-85FD3A38-F78E-4857-8EA3-99A98C0AD795Q33817346-FE6CFA95-FE25-4C47-956A-91A43E6E67A5Q33817695-5912AD6C-E032-4AE2-8C22-C149D962708FQ33838303-CA243E06-1470-4C49-A26F-CF8EBDCE9DA7Q33894661-16506378-8197-44C9-870C-99CC318902AEQ34087126-36A64DCC-A0E6-4E47-A597-00FC2891105BQ34409630-FF070C13-5EAB-4C78-B693-8CB837E41893Q34775357-B0312E00-1C0B-41C9-9A4A-5AC4B38DE8A1Q34994813-1F522EC1-A329-44BE-821F-C571BD150D83Q35079574-B974B08C-1B31-4ABD-A21C-4204DA2303EEQ35086831-BDDBAB47-1EC1-4998-9B32-5F68BF53A4A1Q35286098-BA69B9BB-4240-43A4-8347-B446DD9D8683Q35660733-D37F6513-F021-4510-8972-CE2AA3039A64Q35798834-BCAEFDA7-1243-4567-AA7D-DF4DB7CFB2B4Q36062737-9E8D7401-A423-4B8B-BFAA-EE11CECB0F4DQ36078735-0C992B6A-E188-42D9-8862-42A9E49D4A5DQ36093756-69A4A273-64B0-4D37-A2EC-F575B13F8975Q36149988-064314CB-D1D2-46AA-ABFD-333BE4B28A71Q36315067-C976C32E-2D28-4E2F-BE1D-F1B65C315B1EQ36445216-9D25BC02-3683-46F0-A765-FBCEB462A5BFQ36459384-151DBFC0-A068-47D7-BEEF-C31BAB14BBDBQ36569413-CE9FB5A7-916B-4181-9AE5-8E15A9D1ADE4Q36799911-E3EB3A4E-53AE-4581-B272-05145E7389EFQ36932534-66BE0EBE-F297-4F00-83D3-E8F23F337D3BQ37014362-CB979CFB-1F18-4782-BAA0-440A1D224656Q37071213-E285F272-05AA-4713-AD7B-FA2ABD96E9EBQ37131903-0F4A6E3A-4C76-4476-ADA9-9768219F962CQ37154448-E561C5BC-EAC6-4735-BE82-BAD78E234844Q37776087-1C43DEC1-CCC7-4141-BC46-E36F2AF63A08
P2860
Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Early energy deficit in Huntin ...... le during disease progression.
@ast
Early energy deficit in Huntin ...... le during disease progression.
@en
Early energy deficit in Huntin ...... le during disease progression.
@nl
type
label
Early energy deficit in Huntin ...... le during disease progression.
@ast
Early energy deficit in Huntin ...... le during disease progression.
@en
Early energy deficit in Huntin ...... le during disease progression.
@nl
prefLabel
Early energy deficit in Huntin ...... le during disease progression.
@ast
Early energy deficit in Huntin ...... le during disease progression.
@en
Early energy deficit in Huntin ...... le during disease progression.
@nl
P2093
P2860
P1433
P1476
Early energy deficit in Huntin ...... le during disease progression.
@en
P2093
Anne Vassault
Christiane Coussieu
Christiane Gervais
Daniel Rabier
Fanny Mochel
François Seguin
Guislaine Carcelain
Josué Feingold
Julie Barritault
Laurence Perin
P2860
P356
10.1371/JOURNAL.PONE.0000647
P407
P577
2007-07-25T00:00:00Z